Aridis Pharmaceuticals
Phase 3Mining the human immune response for innovative monoclonal antibodies to combat the growing global health threats such as antibiotic resistance and viral pandemics.
Founded
2003
Focus
AntibodiesBiologicsSmall Molecules
About
Mining the human immune response for innovative monoclonal antibodies to combat the growing global health threats such as antibiotic resistance and viral pandemics.
Funding History
4Total raised: $119M
PIPE$20MUndisclosedJan 15, 2022
Series C$45MUndisclosedJul 15, 2020
Series B$39MUndisclosedFeb 15, 2018
Series A$15MUndisclosedMay 15, 2015
Company Info
TypePrivate
Founded2003
LocationSan Jose, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile